Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact

ClinicalTrials.gov ID: NCT00789477

Public ClinicalTrials.gov record NCT00789477. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 5:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Masked, Randomized, Controlled Study of the Safety, Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, doubled-masked, randomized study of the efficacy and safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in subjects with diabetic macular edema (DME). Approximately 200 subjects will be randomized in the US, Canada, Australia and EU.

Study identification

NCT ID
NCT00789477
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
221 participants

Conditions and interventions

Interventions

Procedure · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2008 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Sep 2010 (Actual)
Last update posted
Sep 9, 2014

2008 – 2010

United States locations

U.S. sites
42
U.S. states
21
U.S. cities
41
Facility City State ZIP Site status
Not listed Artesia California 90701 —
Not listed Beverly Hills California 90211 —
Not listed Mountain View California 94040 —
Not listed Pasadena California 91105 —
Not listed Sacramento California 95819 —
Not listed Santa Ana California 92705 —
Not listed Hamden Connecticut 06518 —
Not listed New London Connecticut 06320 —
Not listed Boynton Beach Florida 33426 —
Not listed Fort Lauderdale Florida 33334 —
Not listed Fort Myers Florida 33912 —
Not listed Ocala Florida 34474 —
Not listed Palm Beach Gardens Florida 33410 —
Not listed Winter Haven Florida 33880 —
Not listed Augusta Georgia 30909 —
Not listed Honolulu Hawaii 96815 —
Not listed Indianapolis Indiana 46280 —
Not listed Bangor Maine 04401 —
Not listed Baltimore Maryland 21287 —
Not listed Boston Massachusetts 02114 —
Not listed Jackson Michigan 48104 —
Not listed Kansas City Missouri 64108 —
Not listed Lincoln Nebraska 68506 —
Not listed New Brunswick New Jersey 08901 —
Not listed Northfield New Jersey 08225 —
Not listed Toms River New Jersey 08753 —
Not listed Rochester New York 14620 —
Not listed Charlotte North Carolina 28210 —
Not listed Raleigh North Carolina 27607 —
Not listed Cincinnati Ohio 45243 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Greenville South Carolina 29605 —
Not listed West Columbia South Carolina 29169 —
Not listed Nashville Tennessee 37203 —
Not listed Abilene Texas 79606 —
Not listed Arlington Texas 76012 —
Not listed Austin Texas 78705 —
Not listed Houston Texas 77030 —
Not listed McAllen Texas 78503 —
Not listed San Antonio Texas 78215 —
Not listed San Antonio Texas 78240 —
Not listed Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00789477, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00789477 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →